An analysis of the high psychotropic off-label use in psychiatric disorders:
The majority of psychiatric diagnoses have no approved drug
To access this article, please choose from the options below
PII: S1876-2018(09)00005-7
doi:10.1016/j.ajp.2009.01.005
© 2009 Elsevier B.V. All rights reserved.
